NIH awards $3.9 million grant to develop innovative drug delivery methods to treat liver cancer

The National Institutes of Health has jointly awarded a $3.9 million grant to Ali Khademhosseini, Ph.D., director and CEO of the Terasaki Institute for Biomedical Innovation (TIBI), and Rami Oklu, Ph.D., M.D., of the Mayo Clinic.